GEN Exclusives

More »

GEN News Highlights

More »
Apr 2, 2007

Roche Strengthens Antibody Research with $56.5M Acquisition

  • Roche paid $56.5 million for antibody technology company Therapeutic Human Polyclonals (THP). The company reports that the acquisition strengthens its expertise in therapeutic antibody research.

    Roche plans to fully integrate THP into the Roche Pharma Center of Excellence for Protein Research organization in Penzberg, Germany.

    A California-based company with a subsidiary in Germany, THP is focused on research in human antibody technologies. The company has developed a transgenic mammalian platform to create human antibodies. Roche reports that this technology will enable it to generate monoclonal and polyclonal antibody therapeutics with enhanced efficacy.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

Be sure to take the GEN Poll

Tackling the Global Problem of Fake Medicines

Policy proposals to address the growing global problem of fake medicines include a global agreement, similar to the Framework Convention on Tobacco Control, and stricter national laws to prosecute those who knowingly sell counterfeit medicines. Do you think these steps will be successful?

More »